Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.25.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 955 $ 527
Accounts receivable, net 24,309 21,155
Inventories, net 5,590 6,528
Other current assets 4,717 3,955
Total current assets 35,571 32,165
Medical equipment for sale or rental 2,931 3,157
Medical equipment in rental service, net of accumulated depreciation 35,262 39,175
Property & equipment, net of accumulated depreciation 3,650 4,030
Goodwill 3,710 3,710
Intangible assets, net 7,077 6,456
Operating lease right of use assets 4,519 5,374
Deferred income taxes 4,812 7,188
Derivative financial instruments 850 1,481
Other assets 499 878
Total assets 98,881 103,614
Current liabilities:    
Accounts payable 10,024 9,848
Other current liabilities 8,694 7,813
Total current liabilities 18,718 17,661
Long-term debt 20,932 23,864
Operating lease liabilities, net of current portion 3,760 4,560
Total liabilities 43,410 46,085
Stockholders’ equity:    
Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued 0 0
Common stock, $0.0001 par value: authorized 200,000,000 shares; 20,327,352 shares issued and outstanding as of September 30, 2025 and 21,272,351 shares issued and outstanding as of December 31, 2024 2 2
Additional paid-in capital 116,259 113,868
Accumulated other comprehensive income 642 1,119
Retained deficit (61,432) (57,460)
Total stockholders’ equity 55,471 57,529
Total liabilities and stockholders’ equity $ 98,881 $ 103,614